Lung Inflammation Overview

Principles

Definition

Lung inflammation is a central concept in respiratory medicine and immunology, encompassing the academic investigation and characterization of the complex cellular, molecular, and physiological mechanisms that constitute inflammatory responses within pulmonary tissues. This field is critical for elucidating the etiology and progression of diverse lung pathologies and informing the development of diagnostic and therapeutic interventions.

Ontological type

Pathophysiology

Therapeutic Strategies

Etiological Factors

Key developments

Key Figures

Exposure‑Driven Inflammation era

Jay A. Nadel [1] was a leading figure in pulmonary inflammation during the mid-20th-century era, with associations to University of California, San Francisco [2] and Stanford University [3]. His work on mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection [4] advanced the understanding of how infections can trigger airway responsiveness, a key link between inflammation and gas-exchange disturbances in this era. These contributions helped integrate quantitative physiology, pathology, and exposure science, illustrating how infection-driven inflammatory processes translate into airway reactivity and aligning with Nadel [1]. By connecting histologic inflammation to functional impairment and recognizing environmental exposures in bronchial reactivity, Jay A. Nadel [1] exemplified the era's emphasis on exposure-driven pathways to pulmonary impairment.

Mediator‑Centric Molecular Paradigm era

Anthony Cerami [1] is a scientist linked to Rockefeller University [3] and the University of California, San Francisco [4] during the Mediator-Centric Molecular Paradigm era. His key contribution in this era centers on the Shock and Tissue Injury Induced by Recombinant Human Cachectin paper [6], which highlighted how a single cytokine can orchestrate systemic inflammation and tissue damage. Kevin J. Tracey [2] is a researcher associated with Rockefeller University [3] and Harvard University [5] during this era. Tracey [2]'s contributions helped define tumor necrosis factor as a pivotal mediator of systemic inflammation and shock, laying the groundwork for the mediator-centric molecular paradigm by linking cytokines to tissue injury and guiding subsequent biomarker and therapeutic strategies [6].

Myeloid Plasticity and Chronicity era

Donald E. Ingber [1] is associated with Harvard University [3] and the University of California, San Francisco [4] in this era, reflecting his influential role across these institutions. Among his contributions this era, the Reconstituting Organ-Level Lung Functions on a Chip [7] helped inaugurate organ-level lung models, enabling study of mechanobiology and inflammatory processes in a controlled microphysiological platform. G. R. Scott Budinger [2] is connected with Northwestern University [5] and University College London [6] in this era. His paper Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span [8] illuminated the durable recruited macrophage state as a driver of chronic lung inflammation and fibrosis, underscoring why targeting myeloid plasticity is crucial for early intervention.